GNC secures Chinese backing
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Health and wellness products retailer GNC has secured a “strategic investment” from China’s Harbin Pharmaceutical, in a move the firm claims will “enhance” its capital position and “accelerate” its global expansion.